News
A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...
Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...
Pennington Biomedical researchers have contributed to a study highlighting the crucial role of cysteine in regulating ...
Adults with obesity were more likely to achieve a 10% or greater weight loss at 1 year if they continued using their ...
MariTide, a groundbreaking weight loss medication, shows 16% weight reduction in trials. Learn about this promising monthly ...
A large network meta-analysis ranked eight GLP-1 receptor agonists for glycemic, weight, and safety outcomes in adults with ...
MariTide helped participants lose up to 20% of their body weight in a year-long trial. But it could be years before the new ...
Linear relationship seen for waist circumference, BP; reduction in HOMA-IR, hemoglobin A1c seen with modest weight reduction.
For adults with obesity or overweight, tirzepatide-linked improvements in cardiometabolic risk factors are associated with ...
11d
Woman's World on MSNNew GLP-1 Called MariTide Shows 20% Weight Loss-Without a PlateauDavid Petrus IbarsIn the same way weight varies from person to person, so do the best weight loss strategies. While some ...
A post hoc analysis of the SRMOUNT-1 study finds weight loss from the use of tirzepatide was associated with strong benefits in measures of cardiometabolic health.
In addition, treatment of hypercortisolism with mifepristone was associated with nearly 10 pounds of weight loss and a reduction in waist circumference of more than two inches.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results